Tilray Brands (TLRY) Return on Invested Capital (2018 - 2026)
Tilray Brands (TLRY) posted Return on Invested Capital of 0.08% for Q1 2026, up 32.43% on a QoQ basis from 0.12% in Q4 2025, and down 4.0% year-over-year from 0.09% in Q1 2025.
Tilray Brands (TLRY) Return on Invested Capital (2018 - 2026) Analysis & Trends
Tilray Brands' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.08% for Q1 2026.
- Quarterly Return on Invested Capital fell 4.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 0.08% (down 4.0% YoY) and the FY2025 annual result came in at 0.5%, down 45.0% from the prior year.
- Return on Invested Capital was 0.08% for Q1 2026 at Tilray Brands, up from 0.12% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.01% in Q4 2024 and bottomed at 0.15% in Q1 2023.
- A 5-year average of 0.07% and a median of 0.05% in 2022 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital soared 84 bps — and 2023, when it decreased 13 bps.
- Tilray Brands' Return on Invested Capital stood at 0.05% in 2022, then slumped by 73 bps to 0.09% in 2023, then surged by 89 bps to 0.01% in 2024, then tumbled by 1163 bps to 0.12% in 2025, then jumped by 32 bps to 0.08% in 2026.
- Business Quant data shows TLRY's Return on Invested Capital at 0.08% in Q1 2026, 0.12% in Q4 2025, and 0.12% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -0.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.08% |
| Nov 30, 2025 | -0.12% |
| Aug 31, 2025 | -0.12% |
| May 31, 2025 | -0.13% |
| Feb 28, 2025 | -0.05% |
| Nov 30, 2024 | -0.01% |
| Aug 31, 2024 | -0.01% |
| May 31, 2024 | -0.01% |
| Feb 29, 2024 | -0.01% |
| Nov 30, 2023 | -0.09% |
| Aug 31, 2023 | -0.10% |
| May 31, 2023 | -0.10% |
| Feb 28, 2023 | -0.15% |
| Nov 30, 2022 | -0.05% |
| Aug 31, 2022 | -0.04% |
| May 31, 2022 | -0.04% |
| Feb 28, 2022 | -0.02% |
| Nov 30, 2021 | -0.02% |
| Aug 31, 2021 | -0.29% |
| May 31, 2021 | -0.88% |